Research Article
Potential Differences in the Cardiometabolic Risk Profile of Patients with Psoriatic Disease according to Their HLA-C06 Status
Table 2
Distribution of variables between HLA-C06-positive versus negative subjects.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yrs: years; SD: standard deviation; : number; PsA: psoriatic arthritis; PASI: psoriasis area and severity index; BMI: body mass index; CHD: coronary heart disease; HDL-C (mg/dl): high-density lipoprotein cholesterol; LDL-C (mg/dl): low-density lipoprotein cholesterol; TG (mg/dl): triglycerides. These values refer to the first visit to the clinic; Student’s -test; chi-square test; Fisher’s exact test. |